Search Results - Maria Fleseriu

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Monitoring Patient Improvement Parameters following Pasireotide Treatment in Cushing’s Disease by Chris Yedinak, Jessica Brzana, Maria Fleseriu

    Published in Case Reports in Endocrinology (2013-01-01)
    Get full text
    Article


  2. 2

    Development of a Novel Algorithm to Identify People with High Likelihood of Adult Growth Hormone Deficiency in a US Healthcare Claims Database by Kevin C. J. Yuen, Anna Camilla Birkegard, Lewis S. Blevins, David R. Clemmons, Andrew R. Hoffman, Nicky Kelepouris, Janice M. Kerr, Jens M. Tarp, Maria Fleseriu

    Published in International Journal of Endocrinology (2022-01-01)
    Get full text
    Article


  3. 3

    Osilodrostat treatment in patients with Cushing’s disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4) by Akira Shimatsu, Beverly MK Biller, Maria Fleseriu, Rosario Pivonello, Eun Jig Lee, Rattana Leelawattana, Jung Hee Kim, Rama Walia, Yerong Yu, Zhihong Liao, Andrea Piacentini, Alberto M Pedroncelli, Peter J Snyder

    Published in Endocrine Journal (2024-12-01)
    Get full text
    Article


  4. 4

    Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease by Richard A. Feelders, Maria Fleseriu, Pinar Kadioglu, Marie Bex, Deyanira González-Devia, Cesar Luiz Boguszewski, Dilek Gogas Yavuz, Heather Patino, Alberto M. Pedroncelli, Alberto M. Pedroncelli, Ricardo Maamari, Arghya Chattopadhyay, Beverly M. K. Biller, Rosario Pivonello

    Published in Frontiers in Endocrinology (2023-10-01)
    Get full text
    Article


Search Tools: